grant
Comparison of In Vivo, In Vitro and AI Tools to Generate Anti-RSV Antibodies
Organization UKRILocation United Kingdom
UKRIUK ResearchGrantActive
Description preview
Respiratory Syncytial Virus (RSV) is the leading cause of lower respiratory tract infections in infants, especially those under six months or with pre-existing conditions. The main target for RSV-neutralising antibodies is the Fusion (F) protein, which contains six key binding sites. Some of these sites change between different forms of the…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click